Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer

2.

novel technique for early myelodysplastic syndrome relapse detection in blood cancer patients.

3.

Aspirin Fails to Boost Survival in Colorectal Cancer Trial

4.

Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts

5.

Research uncovers hidden Australian skin cancer epidemic


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot